Cargando…

High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue

The KRAS mutation status predicts the outcome of treatment with epidermal growth factor receptor targeted agents, and therefore the testing for KRAS mutations has become an important diagnostic procedure. To optimize the quality of this test, we compared the results of the two most commonly used KRA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tol, Jolien, Dijkstra, Jeroen R, Vink-Börger, Marianne E, Nagtegaal, Iris D, Punt, Cornelis JA, Van Krieken, Johan HJM, Ligtenberg, Marjolijn JL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823003/ https://www.ncbi.nlm.nih.gov/pubmed/19453520 http://dx.doi.org/10.1111/j.1582-4934.2009.00788.x

Ejemplares similares

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment
por: Dijkstra, Jeroen R., et al.
Publicado: (2015)

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer
por: Simmer, Femke, et al.
Publicado: (2015)

Mismatch repair deficiency in early‐onset duodenal, ampullary, and pancreatic carcinomas is a strong indicator for a hereditary defect
por: Kryklyva, Valentyna, et al.
Publicado: (2021)

EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer
por: Venderbosch, Sabine, et al.
Publicado: (2015)

Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization
por: de Bitter, Tessa J. J., et al.
Publicado: (2021)

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice
por: Steeghs, Elisabeth M P, et al.
Publicado: (2022)

Pancreatic acinar cell carcinoma is associated with BRCA2 germline mutations: a case report and literature review
por: Kryklyva, Valentyna, et al.
Publicado: (2019)

Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
por: Vogelaar, Ingrid P, et al.
Publicado: (2012)

RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers
por: Boleij, Annemarie, et al.
Publicado: (2015)

Incidental findings in the bowel cancer population screening program: other polyps and malignancies – A nationwide study
por: Nagtegaal, Iris D, et al.
Publicado: (2022)

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014
por: Punt, Cornelis JA, et al.
Publicado: (2015)

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients
por: de Bitter, Tessa J. J., et al.
Publicado: (2022)

Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma
por: Boesaard, Ewout P, et al.
Publicado: (2014)

Functional characterisation of a novel class of in-frame insertion variants of KRAS and HRAS
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

RAS testing in metastatic colorectal cancer: advances in Europe
por: Van Krieken, J Han JM, et al.
Publicado: (2015)

MicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls
por: Dijkstra, J R, et al.
Publicado: (2012)

Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent
por: Mekenkamp, Leonie J. M., et al.
Publicado: (2014)

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing
por: Witjes, Vera M., et al.
Publicado: (2021)

Limited effect of lymph node status on the metastatic pattern in colorectal cancer
por: Knijn, Nikki, et al.
Publicado: (2016)

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
por: Smits, Alexander J. J., et al.
Publicado: (2012)

A national population-based study provides insight in the origin of malignancies metastatic to the ovary
por: Bruls, Jolien, et al.
Publicado: (2015)

Miniaturized Real-Time PCR on a Q3 System for Rapid KRAS Genotyping
por: Guarnaccia, Maria, et al.
Publicado: (2017)

The times have changed: molecular pathology is here to stay: A commentary on: Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma, by Lee et al. In this issue
por: van Krieken, J. Han, et al.
Publicado: (2012)

Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome
por: Vos, Janet R., et al.
Publicado: (2020)

Improving calculation, interpretation and communication of familial colorectal cancer risk: Protocol for a randomized controlled trial
por: Dekker, Nicky, et al.
Publicado: (2010)

SensiScreen(®) KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations
por: Riva, Alice, et al.
Publicado: (2017)

Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS mutations
por: Ha, Dat P., et al.
Publicado: (2022)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
por: Elze, Lisa, et al.
Publicado: (2023)

KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice
por: Sundström, Magnus, et al.
Publicado: (2010)

KRAS Mutation Analysis by PCR: A Comparison of Two Methods
por: Bolton, Louise, et al.
Publicado: (2015)

KRAS genotyping by digital PCR combined with melting curve analysis
por: Tanaka, Junko, et al.
Publicado: (2019)

Improvement of digital PCR conditions for direct detection of KRAS mutations
por: Lee, Jina, et al.
Publicado: (2020)

Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study
por: Nagtegaal, Iris D, et al.
Publicado: (2001)

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
por: Jongeneel, Gabrielle, et al.
Publicado: (2019)

Diagnostic variability in the histopathological assessment of advanced colorectal adenomas and early colorectal cancer in a screening population
por: Smits, Lisanne J H, et al.
Publicado: (2022)

Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival
por: Kryklyva, Valentyna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uk32p47umg78mvmvcee0v1222j